Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production.
Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production.
复制标题
DOI：
--
复制
发表时间：
2002-07
期刊：
影响因子：
11.2
通讯作者：
J. Geschwind;Y. Ko;M. Torbenson;C. Magee;P. Pedersen
中科院分区：
文献类型：
--
作者：
J. Geschwind;Y. Ko;M. Torbenson;C. Magee;P. Pedersen
Most types of cancer are difficult to eradicate and some, like liver carcinomas, are almost always fatal. Significantly, we report here that direct intraarterial delivery of 3-bromopyruvate (3-BrPA), a potent inhibitorof cell ATP production, to liver-implanted rabbit tumors, inflicts a rapid, lethal blow to most cancer cells therein. Moreover, systemic delivery of 3-BrPA suppresses "metastatic" tumors that arise in the lungs. In both cases, there is no apparent harm to other organs or to the animals. Thus, intraarterial delivery of agents like 3-BrPA directly to the site of the primary tumor, followed by systemic delivery only when necessary, may represent a powerful new strategy for arresting the growth of liver and other cancers while minimizing toxic side effects.
